Catalyst Wire Dossier Catalyst Wire Dossier

i3.1 probiotic

i3.1 probiotic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for i3.1 probiotic, covering 2020-01-23 to 2020-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico [Phase 4]

See pricing